| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -8.4% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 0.4 | n/a |
| Pr/Book | 2.1 |
| Latest | F'cast | |
|---|---|---|
| Revenue | -6.8% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 1,613.62 | (534.64) | (66.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 2,179.91 | (186.29) | (13.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 2,239.23 | (549.73) | (44.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 1,879.90 | (92.25) | 8.00p | 10.6 | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 1,751.40 | (202.40) | (13.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Director Declaration | 28-Oct-2025 | 11:14 | RNS |
| Q3 2025 Trading Statement | 14-Oct-2025 | 07:00 | RNS |
| Notice of Trading Update | 10-Oct-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 46.48p |
| Change Today | -0.76p |
| % Change | -1.61 % |
| 52 Week High | 53.90 |
| 52 Week Low | 22.96 |
| Volume | 2,543,234 |
| Shares Issued | 1,390.69m |
| Market Cap | £646.39m |
| Beta | 0.89 |
| RiskGrade | 166 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:59 | 363,672 @ 46.49p |
| 16:35 | 13,130 @ 46.48p |
| 16:35 | 516,458 @ 46.48p |
| 16:35 | 852 @ 46.48p |
| 16:35 | 841 @ 46.48p |
| CEO | Matthew Moulding |
| CFO | Damian Sanders |
| Chair | Charles Allen |
You are here: research